Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 27, 2003

View Archived Issues

Promising results for ferumoxytol in anemia and chronic kidney disease

SBIR grant for PTC Therapeutics' novel antibiotics research

Positive trends in improvement of FEV1 in phase II trial of DCF-987

Peplin Biotech acquires portfolio of polyunsaturated fatty acid compounds

Low systemic toxicity reported for NLCQ-1 in rats

MLN-2704 potentially effective against bone metastases in prostate cancer

Preliminary results for motexafin gadolinium combined with doxorubicin in solid tumors

Good safety profile found for LE-SN-38 in advanced cancer patients

Assessment of two treatment schedules for OSI-7836 in cancer patients

Cetuximab enhances antitumor effects of cisplatin in late-stage clinical trial

Promising results reported for DX-8951f in pediatric cancer

CCI-779 in brain and pediatric tumors

Antitumor effects of lonafarnib unrelated to Ras mutations or the PI3/Akt pathway

Japanese researchers describe protein kinase inhibitors as antineoplastic enhancing agents

Diamyd increases levels of C-peptide in diabetes patients

New GSK-3 inhibitors and their use covered by AstraZeneca patent

Trigen identifies new antithrombotic compounds

Yissum presents multifunctional agents for asthma and other respiratory diseases

GSK scientists describe novel p38 kinase inhibitors in a recent patent

Novel EGFR inhibitors under study at Boehringer Ingelheim

Potassium Kv1.5 channel blockers reported by BMS and ICAgen researchers

Sanofi-Synthelabo claims novel GlyT inhibitors

Allergan submits NDA for oral tazarotene for psoriasis

Final pivotal study of exenatide reports positive results

PROTERM trial evaluates Prochieve for prevention of preterm delivery

Phase III program commences for PTI-901 in IBS

Metvix approved in Switzerland

Pilot study of SWT-01.100 supports mode of action for treatment of psoriasis

Vasogen chooses brand name for immune modulation therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...